Smith & Nephew expands wound care offering with Healthpoint buy

11/29/2012 | Bloomberg

Smith & Nephew has agreed to pay $782 million to acquire Healthpoint Biotherapeutics, maker of the Santyl ointment used to debride wounds of dead tissue. The deal is expected to allow Smith & Nephew to gain a foothold in the bioactive wound care market and strengthen its advanced wound management business, CEO Olivier Bohuon said.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN